Fig. 2
From: Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-017-1492-9/MediaObjects/13075_2017_1492_Fig2_HTML.gif)
Validation-phase serum expression levels of candidate miRNAs. Baseline and follow-up relative expression in the progressor (P) and non-progressor (NP) cohorts of miR-486-3p, miR-22 and miR-382 (a) and miR-203 and miR-579 (b). HC, healthy controls; dCt, delta cycle threshold